Meeting
2017 ASCO Annual Meeting
Genomic alterations (GA) and tumor mutational burden (TMB) in large cell neuroendocrine carcinoma of lung (L-LCNEC) as compared to small cell lung carcinoma (SCLC) as assessed via comprehensive genomic profiling (CGP).
Authors
Young Kwang Chae
Northwestern Medicine Developmental Therapeutics Institute, Chicago, IL
Young Kwang Chae , Keerthi Tamragouri , Jon Chung , Alexa Betzig Schrock , Bhaskar Kolla , Shridar Ganesan , James Suh , Vamsidhar Velcheti , Trever Grant Bivona , Jeffrey S. Ross , Phil Stephens , Vincent A. Miller , Manish Patel , Francis J. Giles , Siraj Mahamed Ali , Sai-Hong Ignatius Ou , Victoria Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8517)
DOI
10.1200/JCO.2017.35.15_suppl.8517
Abstract #
8517
Poster Bd #
253
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim
Poster
2015 ASCO Annual Meeting
Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program.
First Author: Sarina Anne Piha-Paul
Poster
2020 ASCO Virtual Scientific Program
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
First Author: Yutaro Tamiya
Poster
2019 ASCO Annual Meeting
Characterization of genomic alterations in Chinese LCNEC and SCLC via comprehensive genomic profiling.
First Author: Lin Wu